Analysis Novo Nordisk Faces US Lawsuits Over Vision Damage Claims While Racing to Defend Its GLP-1 Empire
Novo Nordisk’s legal headaches in the United States are piling up at the worst possible moment. Hundreds of patients have filed suit against the Danish drugmaker and its American rival...